InsiderClue
Insiders · Profile

Winningham Rick E

Director at Jazz Pharmaceuticals · CHIEF EXECUTIVE OFFICER at Theravance Biopharma · Chief Executive Officer at Innoviva. Filing since 11 Mar 2008. CIK 0001302443

JAZZ Jazz Pharmaceuticals plc Director · 16 trades TBPH Theravance Biopharma, Inc. CHIEF EXECUTIVE OFFICER · 4 trades INVA Innoviva, Inc. Chief Executive Officer · 12 trades
Company
Date
Role
Action
Shares
Amount
Of holding
JAZZ Jazz Pharmaceuticals plc
22 May 2026
Director
Sold at will
2,741
$662.14K
22.3%
JAZZ Jazz Pharmaceuticals plc
18 Nov 2025
Director
Sold at will
5,500
$994.73K
38.2%
JAZZ Jazz Pharmaceuticals plc
14 Aug 2023
Director
Sold at will
1,241
$171.45K
10.6%
TBPH Theravance Biopharma, Inc.
14 Dec 2022
CHIEF EXECUTIVE OFFICER
Sold, plan not stated
50,000
$559.50K
3.6%
JAZZ Jazz Pharmaceuticals plc
8 Aug 2022
Director
Sold, plan not stated
1,089
$165.88K
11.2%
JAZZ Jazz Pharmaceuticals plc
6 Aug 2021
Director
Sold, plan not stated
1,306
$193.24K
15.5%
JAZZ Jazz Pharmaceuticals plc
7 Aug 2020
Director
Sold, plan not stated
931
$117.18K
13.1%
JAZZ Jazz Pharmaceuticals plc
9 Aug 2019
Director
Sold, plan not stated
726
$98.48K
14.1%
JAZZ Jazz Pharmaceuticals plc
10 Aug 2018
Director
Sold, plan not stated
660
$116.56K
11.8%
JAZZ Jazz Pharmaceuticals plc
9 Aug 2018
Director
Sold, plan not stated
15,979
$2.81M
74.0%
TBPH Theravance Biopharma, Inc.
11 Aug 2017
Chief Executive Officer
Bought
10,000
$245.00K
1.2%
JAZZ Jazz Pharmaceuticals plc
11 Aug 2017
Director
Sold, plan not stated
662
$94.25K
5.6%
JAZZ Jazz Pharmaceuticals plc
1 Jun 2017
Director
Sold, plan not stated
5,000
$750.00K
32.5%
JAZZ Jazz Pharmaceuticals plc
15 Aug 2016
Director
Sold, plan not stated
633
$86.37K
4.0%
TBPH Theravance Biopharma, Inc.
17 Aug 2015
Chief Executive Officer
Bought
16,860
$204.51K
2.9%
TBPH Theravance Biopharma, Inc.
14 Aug 2015
Chief Executive Officer
Bought
63,140
$744.42K
12.1%
JAZZ Jazz Pharmaceuticals plc
10 Aug 2015
Director
Sold, plan not stated
801
$144.18K
5.2%
JAZZ Jazz Pharmaceuticals plc
12 Aug 2014
Director
Sold, plan not stated
1,087
$144.73K
7.1%
JAZZ Jazz Pharmaceuticals plc
17 Apr 2014
Director
Sold, plan not stated
27,500
$3.85M
66.9%
INVA Innoviva, Inc.
12 Sep 2013
Chief Executive Officer
Sold, plan not stated
22,353
$894.79K
3.1%
JAZZ Jazz Pharmaceuticals plc
13 Aug 2013
Director
Sold, plan not stated
1,070
$87.59K
2.5%
INVA Innoviva, Inc.
30 Apr 2013
Chief Executive Officer
Sold, plan not stated
255,532
$8.60M
26.2%
INVA Innoviva, Inc.
3 Aug 2012
Chief Executive Officer
Sold, plan not stated
75,749
$2.12M
11.4%
INVA Innoviva, Inc.
11 May 2011
Chief Executive Officer
Sold, plan not stated
73,100
$1.92M
13.1%
INVA Innoviva, Inc.
10 May 2011
Chief Executive Officer
Sold, plan not stated
54,646
$1.44M
8.9%
INVA Innoviva, Inc.
1 Mar 2011
Chief Executive Officer
Sold, plan not stated
63,873
$1.44M
9.4%
INVA Innoviva, Inc.
28 Feb 2011
Chief Executive Officer
Sold, plan not stated
67,000
$1.54M
9.0%
INVA Innoviva, Inc.
25 Feb 2011
Chief Executive Officer
Sold, plan not stated
92,200
$2.07M
12.5%
INVA Innoviva, Inc.
24 Feb 2011
Chief Executive Officer
Sold, plan not stated
93,100
$2.00M
13.4%
INVA Innoviva, Inc.
23 Feb 2011
Chief Executive Officer
Sold, plan not stated
97,600
$2.06M
14.9%
INVA Innoviva, Inc.
22 Feb 2011
Chief Executive Officer
Sold, plan not stated
168,800
$3.62M
24.8%
INVA Innoviva, Inc.
11 Mar 2008
Chief Executive Officer
Bought
20,000
$209.42K
86.5%
32 decisions on file.